FDA Alerts Public Unsafe Hydrocortisone Injection
The Food and Drugs Authority (FDA) has raised a red flag regarding the distribution, supply, or purchase Hydrocortisone Injection B.P 100mg.
The unsafe medication manufactured by Ambica Pharma Sales in India can be identified by the name―Hydrocortisone Sodium Succinate Injection B.P 100mg, has a batch number 5AE01007 with expiring date―09/2018.
In a statement signed by the Chief Executive Officer of FDA, Mrs Delese Darko and copied to various media houses, laboratory analysis of the product, detected a lack of uniformity of content which makes it unsafe and unfit for use.
The Authority has therefore commenced the immediate withdrawal of the product from health facilities and pharmaceutical suppliers that may have stocks.
All healthcare professionals and facilities have also been directed to immediately check their medical suppliers and quarantine any affected product, labelled as stated above and return them to the suppliers or the FDA.
“Healthcare professionals and suppliers of pharmaceutical products are encouraged to obtain any medications they administer or provide to consumers from reliable sources that adhere to proper quality standards,” the statement read.
The FDA says it would continue to do all within its mandate to ensure the safety and efficacy of all products found in the Ghanaian market.
The authority urges the public and healthcare professionals to report all adverse reactions, quality problems or any practice suspected to be against public health and safety to any of the hotlines: 0299802932, 0299802933; short code―4015 (on all networks except GLO)
By: Grace Ablewor Sogbey/ email@example.com